Featured Story

New Lassa Fever Therapeutics Study

VHFC researchers from Texas, New Orleans and Sierra Leone have published a study demonstrating the efficacy of a human-monoclonal-antibody therapy on nonhuman primates against Lassa Fever. Read more

PSD to Drupal theme